Glomerular nephrotoxicity of aminoglycosides Martínez-Salgado C, López-Hernández FJ, López-Novoa JM. Toxicology and Applied Pharmacology 223:86-98. FI: 3.359 (Q1) Effect of the flavonoid querecetin on cadmium-induced hepatotoxicity Vicente-Sánchez C, Egido J, Sánchez-González PD, Pérez-Barriocanal F, López-Novoa JM, Morales AI. Food and Chemical Toxicology 46(6):2279-2287. FI: 2.114 (Q1) Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis Mollinedo F, Gajate C, Morales AI, del Canto-Jañez E, Justies N, Collía F, Rivas JV, Modolell M, Iglesias A. Journal of Pharmacology and Experimental 329(2):439-449. FI: 4.093 (Q1) Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway Morales AI, Detaille D, Prieto M, Puente A, Briones E, Arévalo M, Leverve X, López-Novoa JM, El-Mir MY. Kidney International 77(10):861-869. FI: 6.193 (Q1) New therapies: calcimimetics, phosphate binders and vitamin D receptor activators Cannata-Andía JB, Rodriguez-García M, Román-García P, Tuñón-le Poultel D, López-Hernández F, Rodríguez-Puyol D. Pediatric Nephrology 25:609-616. FI: 2.425 (Q1) An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease García-Sánchez O, López-Hernández FJ, López-Novoa JM. Kidney International 77:950-955. FI: 6.193 (Q1) Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency Naves-Díaz M, Carrillo-López N, Rodríguez-Rodríguez A, Braga S, Fernández-Coto T, Lopez-Novoa JM, López-Hernández F, Cannata-Andía JB. Menopause 17:766-771. FI: 3.082 (Q1) Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspect López-Novoa JM, Martínez-Salgado C, Rodríguez-Peña AB, López-Hernández FJ. Pharmacology & Therapeutics 128:61-81. FI: 8.897( Q1) Apoptotic volume decrease as a geometric determinant of cell dismantling into apoptotic bodies Núñez R, Sancho-Martínez SM, Novoa JM, López-Hernández FJ. Cell Death and Differentiation 17:1665-1671. FI: 8.240 (Q1) Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein Quiros Y, Ferreira L, Sancho-Martínez SM, González-Buitrago JM, López-Novoa JM, López-Hernández FJ. Kidney International 78:1006-1015. FI: 6.193 (Q1)
|
